Another newly described and annotated lncRNA in breast cancer is GUARDIN, a p53-responsive lncRNA, that can sustain cancer cell growth via two key mechanisms; sequestering miR-23a which in turn stabilizes TRF2 and acting as an RNA scaffold for the oncoprotein BRCA1. This evidence concerns the gene TP53 and cancer.